Literature DB >> 22798259

Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.

Shashi Prasad1, Virginia Cody, Jennifer K Saucier-Sawyer, Tarek R Fadel, Richard L Edelson, Martin A Birchall, Douglas J Hanlon.   

Abstract

PURPOSE: In order to investigate Poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NP) as potential vehicles for efficient tumor antigen (TA) delivery to dendritic cells (DC), this study aimed to optimize encapsulation/release kinetics before determining immunogenicity of antigen-containing NP.
METHODS: Various techniques were used to liberate TA from cell lines. Single (gp100) and multiple (B16-tumor lysate containing gp100) antigens were encapsulated within differing molecular weight PLGA co-polymers. Differences in morphology, encapsulation/release and biologic potency were studied. Findings were adopted to encapsulate fresh tumor lysate from patients with advanced tumors and compare stimulation of tumor infiltrating lymphocytes (TIL) against that achieved by soluble lysate.
RESULTS: Four cycles of freeze-thaw + 15 s sonication resulted in antigen-rich lysates without the need for toxic detergents or protease inhibitors. The 80 KDa polymer resulted in maximal release of payload and favorable production of immunostimulatory IL-2 and IFN-γ. NP-mediated antigen delivery led to increased IFN-γ and decreased immunoinhibitory IL-10 synthesis when compared to soluble lysate.
CONCLUSIONS: Four cycles of freeze-thaw followed by 15 s sonication is the ideal technique to obtain complex TA for encapsulation. The 80 KDa polymer has the most promising combination of release kinetics and biologic potency. Encapsulated antigens are immunogenic and evoke favorable TIL-mediated anti-tumor responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798259      PMCID: PMC4075113          DOI: 10.1007/s11095-012-0787-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

Review 1.  European union regulatory developments for new vaccine adjuvants and delivery systems.

Authors:  Dorothea Sesardic; Roland Dobbelaer
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

2.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.

Authors:  D Wang; D R Robinson; G S Kwon; J Samuel
Journal:  J Control Release       Date:  1999-01-04       Impact factor: 9.776

3.  Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.

Authors:  G F Kersten; D Donders; A Akkermans; E C Beuvery
Journal:  Vaccine       Date:  1996-12       Impact factor: 3.641

4.  PELA microspheres loaded H. pylori lysates and their mucosal immune response.

Authors:  Jian-Min Ren; Quan-Ming Zou; Fu-Kun Wang; Qiang He; Wei Chen; Wen-Kun Zen
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.

Authors:  K S Jaganathan; Paramjit Singh; D Prabakaran; Vivek Mishra; Suresh P Vyas
Journal:  J Pharm Pharmacol       Date:  2004-10       Impact factor: 3.765

6.  Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.

Authors:  S P Schwendeman; H R Costantino; R K Gupta; M Tobio; A C Chang; M J Alonso; G R Siber; R Langer
Journal:  Dev Biol Stand       Date:  1996

Review 7.  Solid-phase aggregation of proteins under pharmaceutically relevant conditions.

Authors:  H R Costantino; R Langer; A M Klibanov
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

8.  Preparation and characterization of biodegradable microspheres containing hepatitis B surface antigen.

Authors:  Shaobing Zhou; Xueyan Liao; Zhenglun Liang; Xiaohong Li; Xianmo Deng; Heming Li
Journal:  Macromol Biosci       Date:  2004-01-21       Impact factor: 4.979

9.  Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Authors:  Willem W Overwijk; Marc R Theoret; Steven E Finkelstein; Deborah R Surman; Laurina A de Jong; Florry A Vyth-Dreese; Trees A Dellemijn; Paul A Antony; Paul J Spiess; Douglas C Palmer; David M Heimann; Christopher A Klebanoff; Zhiya Yu; Leroy N Hwang; Lionel Feigenbaum; Ada M Kruisbeek; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Non-invasive administration of biodegradable nano-carrier vaccines.

Authors:  Mohd Abul Kalam; Abdul Arif Khan; Aws Alshamsan
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

2.  In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.

Authors:  Yun Hu; Zongmin Zhao; Marion Ehrich; Kristel Fuhrman; Chenming Zhang
Journal:  Polymer (Guildf)       Date:  2015-12-02       Impact factor: 4.430

3.  Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles.

Authors:  Rutika A Kokate; Sanjay I Thamake; Pankaj Chaudhary; Brittney Mott; Sangram Raut; Jamboor K Vishwanatha; Harlan P Jones
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 4.  The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

Authors:  Michele Graciotti; Cristiana Berti; Harm-Anton Klok; Lana Kandalaft
Journal:  J Transl Med       Date:  2017-06-19       Impact factor: 5.531

5.  Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation.

Authors:  Ya-Wun Yang; Wen-Hui Luo
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 6.  Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Authors:  Qiang Xu; Meiyu Fang; Jing Zhu; Haoru Dong; Jun Cao; Lin Yan; Fransisca Leonard; Felix Oppel; Holger Sudhoff; Andreas M Kaufmann; Andreas E Albers; Xu Qian
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

7.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.